Of course, no one-size-fits-all chart can capture everyones reality
They first became popular in 2019 and since then, they have steadily grown in appeal due our culture being more concerned with self-improvement and optimisation
A 2022 study in International Journal of Molecular Sciences found that BPC-157 reduced pro-inflammatory cytokines (e.g., TNF- and IL-6) while increasing anti-inflammatory cytokines (e.g., IL-10), creating a balanced immune response (Sikiric et al., 2022)
GLP-1 brands have been steadily expanding their reach through new indications, with Ozempic and Wegovy adding cardiovascular risk reduction in 2020 and 2024 respectively, and Zepbound adding obstructive sleep apnea in 2024
+ There is no single nationally mandated lab panel, but the standard of care has converged on a baseline workup that includes a hemoglobin A1c, fasting lipid panel, comprehensive metabolic panel (which captures kidney and liver function), and TSH where thyroid status is unclear or symptomatic